Navigation Links
Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence

PARSIPPANY, N.J., Sept. 8 /PRNewswire/ -- Today every major pharmaceutical industry executive searches for ways to succeed when looking toward the future of pharma.  In an unprecedented move, they're all coming together in just a few weeks.  All the big names in pharma.  All in one place.  That's the scene you'll find on September 21-22, 2010 at the Pharma CI Conference & Exhibition at the Hilton Parsippany Hotel in Parsippany, New Jersey, USA.  In fact, more than 250 pharma thought leaders have already signed up.  And with each day, more people say they want to be part of this historic, high quality event.  To see who's coming so far, go to

This comprehensive conference is geared toward anyone who has a stake in the pharmaceutical marketplace.  It's truly an eye-opening experience for anyone interested in what happens next for pharma giants, as well as up-and-comers.

Pharmaceutical decision makers say they want the most accurate and up-to-date information about the pharma industry, especially pharmaceutical competitive intelligence.  It's the kind of data only true experts can provide.  And these experts are all coming to the Pharma CI Conference & Exhibition.   More than 75 preeminent speakers will delve into current and future hot topics.  To see the speaker list, go to

The Pharma CI Conference is the industry's gold standard for senior level pharma, biotech, and medical device professionals seeking the latest in competitive intelligence and business intelligence.  


  • Unparalleled Networking: Meet hundreds of peers in just two days.
  • Superior Speakers: 75+ senior level speakers with depth of knowledge found nowhere else.  
  • Expansive Coverage: 50+ sessions (presentations, panel and roundtable discussions, and workshops) cover every important topic.

2010 sponsors/exhibitors include:

Fletcher/CSI, Deallus, Fuld & Company, Applied Intelligence, Aurora WDC, BCC Research, Best Practices, BioMedTracker, Brady Corp, Capital IQ, CBR Pharma Insights, Digimind, Dow Jones, dtw, Dunn Group, EvaluatePharma, Evalueserve, Financial Times, FirstWord, Indegene, Larvol Group, Lifescience Dynamics, MedPredict, Murray Hill Center, Northern Light, PharmaForce, PharmaVoxx, Prescient Life Sciences, Proactive Worldwide, research reporter, SAI MedPartners, Search Technology, Sedulo Group, ValueCentric, and Wolters Kluwer Pharma Solutions.  

For more information or registration, go to, call 212.228.7974/713.398.6888 or email

SOURCE Pharma CI Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. ( Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving ... has dropped below 10,000 for the first time since 2011. In 2014, there were ... to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):